Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Sells 14,692 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 14,692 shares of the company’s stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $15.43, for a total transaction of $226,697.56. Following the completion of the transaction, the chief financial officer now owns 1,402,862 shares of the company’s stock, valued at approximately $21,646,160.66. This trade represents a 1.04 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Robert Thomas Freeman also recently made the following trade(s):

• On Thursday, March 6th, Robert Thomas Freeman sold 218,295 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total value of $3,390,121.35.
• On Tuesday, March 4th, Robert Thomas Freeman sold 250,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.58, for a total value of $3,895,000.00.

Alignment Healthcare Stock Up 1.9 %

Shares of Alignment Healthcare stock opened at $15.79 on Friday. Alignment Healthcare, Inc. has a 12-month low of $4.46 and a 12-month high of $16.25. The firm has a market capitalization of $3.03 billion, a PE ratio of -20.51 and a beta of 1.49. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The stock’s fifty day moving average is $14.38 and its 200-day moving average is $12.43.

Analyst Upgrades and Downgrades

ALHC has been the subject of several research analyst reports. JPMorgan Chase & Co. upped their price objective on shares of Alignment Healthcare from $14.00 to $17.00 and gave the stock a “neutral” rating in a report on Thursday, March 6th. William Blair reiterated an “outperform” rating on shares of Alignment Healthcare in a report on Friday, February 28th. Stephens reissued an “overweight” rating and set a $17.00 target price on shares of Alignment Healthcare in a report on Monday, February 24th. Piper Sandler increased their price target on Alignment Healthcare from $14.00 to $21.00 and gave the company an “overweight” rating in a research note on Tuesday, March 4th. Finally, Stifel Nicolaus boosted their price objective on Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a research note on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Alignment Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $14.83.

Institutional Trading of Alignment Healthcare

Institutional investors and hedge funds have recently bought and sold shares of the stock. Mackenzie Financial Corp boosted its holdings in shares of Alignment Healthcare by 149.8% in the fourth quarter. Mackenzie Financial Corp now owns 85,175 shares of the company’s stock worth $958,000 after buying an additional 51,084 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Alignment Healthcare by 15.9% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 263,203 shares of the company’s stock worth $2,961,000 after purchasing an additional 36,151 shares during the period. Voloridge Investment Management LLC acquired a new stake in Alignment Healthcare during the 4th quarter valued at $189,000. Squarepoint Ops LLC lifted its holdings in shares of Alignment Healthcare by 414.6% in the fourth quarter. Squarepoint Ops LLC now owns 198,309 shares of the company’s stock valued at $2,231,000 after purchasing an additional 159,774 shares in the last quarter. Finally, Two Sigma Investments LP acquired a new stake in shares of Alignment Healthcare in the fourth quarter worth $258,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.